Kristen Kluska

Stock Analyst at Cantor Fitzgerald

(4.76)
# 650
Out of 5,134 analysts
403
Total ratings
43.1%
Success rate
17.2%
Average return

Stocks Rated by Kristen Kluska

Monopar Therapeutics
Nov 12, 2026
Upgraded: Buy
Price Target: $119
Current: $72.00
Upside: +65.28%
Lexeo Therapeutics
Nov 11, 2026
Reiterated: Buy
Price Target: $23
Current: $2.87
Upside: +701.39%
Capricor Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $28
Current: $9.53
Upside: +193.81%
Eupraxia Pharmaceuticals Inc.
Nov 10, 2026
Reiterated: Buy
Price Target: $27.12
Current: $11.65
Upside: +132.75%
Rigel Pharmaceuticals
Nov 8, 2026
Reiterated: Hold
Price Target: $47
Current: $44.46
Upside: +5.71%
Kardigan
Nov 7, 2026
Reiterated: Buy
Price Target: $50
Current: $13.82
Upside: +261.79%
ADMA Biologics
Nov 5, 2026
Reiterated: Hold
Price Target: $12 → $13
Current: $13.68
Upside: -4.97%
Celldex Therapeutics
Nov 5, 2026
Reiterated: Buy
Price Target: $72
Current: $28.83
Upside: +149.74%
Egetis Therapeutics AB (publ)
Nov 5, 2026
Downgraded: Hold
Price Target: kr 33.00 → kr 11.25
Current: kr 11.20
Upside: +0.45%
Sarepta Therapeutics
Nov 5, 2026
Reiterated: Hold
Price Target: $21
Current: $16.07
Upside: +30.68%
Reiterated: Buy
Price Target: $39
Current: $16.08
Upside: +142.54%
Reiterated: Buy
Price Target: $87
Current: $29.72
Upside: +192.73%
Reiterated: Buy
Price Target: $25
Current: $9.08
Upside: +175.33%
Reiterated: Buy
Price Target: $137
Current: $63.49
Upside: +115.78%
Reiterated: Buy
Price Target: $48
Current: $11.02
Upside: +335.77%
Reiterated: Buy
Price Target: $441
Current: $273.09
Upside: +61.49%
Initiated Coverage: Buy
Price Target: $6
Current: $0.9999
Upside: +500.06%
Reiterated: Buy
Price Target: n/a
Current: $6.06
Upside: -
Rated: Buy
Price Target: $125 → $170
Current: $80.00
Upside: +112.50%
Reiterated: Buy
Price Target: $25
Current: $7.51
Upside: +232.89%
Reiterated: Buy
Price Target: $28 → $30
Current: $2.42
Upside: +1,139.67%
Reiterated: Buy
Price Target: $3
Current: $0.3075
Upside: +875.61%
Reiterated: Buy
Price Target: $26
Current: $6.84
Upside: +280.12%
Reiterated: Buy
Price Target: $11
Current: $1.16
Upside: +848.28%
Reiterated: Buy
Price Target: $19
Current: $4.10
Upside: +363.41%
Reiterated: Buy
Price Target: $16
Current: $6.35
Upside: +151.97%
Reiterated: Buy
Price Target: $11
Current: $3.91
Upside: +181.33%
Upgraded: Buy
Price Target: n/a
Current: $23.81
Upside: -
Reiterated: Buy
Price Target: $15 → $24
Current: $3.77
Upside: +536.60%
Reiterated: Hold
Price Target: $16
Current: $1.09
Upside: +1,367.89%
Reiterated: Buy
Price Target: $14
Current: $3.12
Upside: +348.72%
Reiterated: Buy
Price Target: $6 → $7
Current: $0.5584
Upside: n/a
Rated: Buy
Price Target: n/a
Current: $3.98
Upside: n/a
Reiterated: Buy
Price Target: $6
Current: $0.9146
Upside: n/a
Downgraded: Hold
Price Target: $4 → $20
Current: $0.413
Upside: n/a
Reiterated: Buy
Price Target: $23
Current: $13.38
Upside: n/a
Reiterated: Buy
Price Target: $27
Current: $1.64
Upside: n/a
Reiterated: Buy
Price Target: $17
Current: $21.60
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $1.53
Upside: n/a
Reiterated: Buy
Price Target: $3.5 → $28
Current: $0.1141
Upside: n/a
Downgraded: Hold
Price Target: $28 → $20
Current: $0.0001
Upside: n/a
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Reiterated: Hold
Price Target: $4.25 → $10
Current: $0.7317
Upside: n/a
Initiated Coverage: Buy
Price Target: $180
Current: $1.68
Upside: n/a
Reiterated: Hold
Price Target: $4
Current: $0.8278
Upside: n/a
Reiterated: Buy
Price Target: $10
Current: $0.4214
Upside: n/a
Initiated Coverage: Buy
Price Target: $22
Current: $0.0002
Upside: n/a
Initiated Coverage: Buy
Price Target: $9
Current: $0.371
Upside: n/a